Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Botox for Ischemic Digits in Raynaud's Disease
NCT01309802Phase 2Completed
- Sponsor
- Southern Illinois University
- Start
- May 2011
- Primary completion
- May 2016
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of botulinum toxin type A in Raynaud disease, sponsored by Southern Illinois University. Started May 2011; status: completed.
02
Drugs
botulinum toxin type A
03
Conditions
Raynaud disease
Beyond the preview
Go deeper on NCT01309802.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01309802.